Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03438396
Title A Trial of Tisotumab Vedotin in Cervical Cancer
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors Genmab
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | SWE | ITA | ESP | DNK | DEU | CZE | BEL


No variant requirements are available.